Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma

Histopathology

Volumn 64, Issue 5, 2014, Pages 647-659

  Kwon, Sun Young ^a   Bae, Young Kyung ^b   Gu, Mi Jin ^b   Choi, Jung Eun ^b   Kang, Su Hwan ^b   Lee, Soo Jung ^b   Kim, Aeri ^c   Jung, Hye Ra ^a   Kang, Sun Hee ^a   Oh, Hoon Kyu ^d   Park, Ji Young ^e  

^a Keimyung University School of Medicine   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c Daegu Fatima Hospital   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

Author keywords

Breast neoplasms; Neuroendocrine differentiation; Prognosis

Indexed keywords

CHROMOGRANIN A; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; SYNAPTOPHYSIN; CHGA PROTEIN, HUMAN; ESTROGEN RECEPTOR; SYP PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; NEUROENDOCRINE SYSTEM; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR CELL; ADULT; AGED; BREAST TUMOR; CELL DIFFERENTIATION; FEMALE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; NEUROENDOCRINE TUMOR; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIFFERENTIATION; CHROMOGRANIN A; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84896117667     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12306     Document Type: Article

References (23)

1. Miremadi A, Pinder SE, Lee AH et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 2002; 40; 215-222.
2. Makretsov N, Gilks CB, Coldman AJ et al. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum. Pathol. 2003; 34; 1001-1008.
3. Ellis IO, Schnitt SJ, Sastre-Garau X et al. Invasive breast carcinoma. In Tavassoli FA, Devilee P eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003; 32-34.
4. Righi L, Sapino A, Marchio C et al. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems. Semin. Diagn. Pathol. 2010; 27; 69-76.
5. Bussolati G, Badve S. Carcinomas with neuroendocrine features. In Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ eds. WHO classification of tumors of the breast. Lyon: IARC Press, 2012; 62-63.
6. Wei B, Ding T, Xing Y et al. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer 2010; 116; 4463-4473.
7. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19; 403-410.
8. Hammond ME, Hayes DF, Dowsett M et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 2010; 28; 2784-2795.
9. Wolff AC, Hammond ME, Schwartz JN et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol. 2007; 25; 118-145.
10. Fetissof F, Dubois MP, Arbeille-Brassart B et al. Argyrophilic cells in mammary carcinoma. Hum. Pathol. 1983; 14; 127-134.
11. Bussolati G, Gugliotta P, Sapino A et al. Chromogranin-reactive endocrine cells in argyrophilic carcinomas ('carcinoids') and normal tissue of the breast. Am. J. Pathol. 1985; 120; 186-192.
12. Nesland JM, Lunde S, Holm R et al. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells. Histol. Histopathol. 1987; 2; 73-77.
13. Kawasaki T, Mochizuki K, Yamauchi H et al. Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance. J. Clin. Pathol. 2012; 65; 699-703.
14. Miura K, Nasu H, Ogura H. Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast: a case report and hypothesis of neuroendocrine tumor development. Pathol. Int. 2012; 62; 331-334.
15. Sapino A, Righi L, Cassoni P et al. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin. Diagn. Pathol. 2000; 17; 127-137.
16. Shin SJ, DeLellis RA, Ying L et al. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am. J. Surg. Pathol. 2000; 24; 1231-1238.
17. Latif N, Rosa M, Samian L et al. An unusual case of primary small cell neuroendocrine carcinoma of the breast. Breast J. 2010; 16; 647-651.
18. Menendez P, Garcia E, Rabadan L et al. Primary neuroendocrine breast carcinoma. Clin. Breast Cancer 2012; 12; 300-303.
19. Rovera F, Masciocchi P, Coglitore A et al. Neuroendocrine carcinomas of the breast. Int. J. Surg. 2008; 6(Suppl 1); S113-S115.
20. Scopsi L, Andreola S, Pilotti S et al. Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters. Am. J. Surg. Pathol. 1992; 16; 561-576.
21. van Krimpen C, Elferink A, Broodman CA et al. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study. Breast 2004; 13; 329-333.
22. Tang F, Wei B, Tian Z et al. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology 2011; 59; 106-115.
23. Tse GM, Ma TK, Chu WC, Lam WW, Poon CS, Chan WC. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters. Mod. Pathol. 2004; 17; 568-572.